INST Instructure | $23.39
+0.8% | 7/26/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | N/A | View details for BTIG Research rating of Instructure (NYSE:INST) on 7/26/2024 |
TXRH Texas Roadhouse | $169.38
+2.0% | 7/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $175.00 -> $190.00 | Low | View details for BTIG Research rating of Texas Roadhouse (NASDAQ:TXRH) on 7/26/2024 |
TYL Tyler Technologies | $590.65
+4.7% | 7/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $550.00 -> $630.00 | Low | View details for BTIG Research rating of Tyler Technologies (NYSE:TYL) on 7/26/2024 |
DXCM DexCom | $64.00
-40.7% | 7/26/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $156.00 -> $120.00 | Low | View details for BTIG Research rating of DexCom (NASDAQ:DXCM) on 7/26/2024 |
ZTS Zoetis | $179.84
-0.5% | 7/25/2024 | Initiated by | BTIG Research | Analyst M. Massaro | Buy | $220.00 | Low | View details for BTIG Research rating of Zoetis (NYSE:ZTS) on 7/25/2024 |
IDXX IDEXX Laboratories | $469.71
-0.2% | 7/25/2024 | Initiated by | BTIG Research | Analyst M. Massaro | Buy | $580.00 | Low | View details for BTIG Research rating of IDEXX Laboratories (NASDAQ:IDXX) on 7/25/2024 |
|
PTGX Protagonist Therapeutics | $40.28
-3.1% | 7/24/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $41.00 -> $51.00 | Low | View details for BTIG Research rating of Protagonist Therapeutics (NASDAQ:PTGX) on 7/24/2024 |
PHM PulteGroup | $130.02
+4.0% | 7/24/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $133.00 -> $139.00 | Low | View details for BTIG Research rating of PulteGroup (NYSE:PHM) on 7/24/2024 |
EXPI eXp World | $14.64
+3.8% | 7/23/2024 | Upgraded by | BTIG Research | Analyst S. Bhonsle | Sell -> Neutral | | Low | View details for BTIG Research rating of eXp World (NASDAQ:EXPI) on 7/23/2024 |
STC Stewart Information Services | $73.26
+1.3% | 7/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $68.00 -> $80.00 | Low | View details for BTIG Research rating of Stewart Information Services (NYSE:STC) on 7/22/2024 |
INST Instructure | $23.39
+0.8% | 7/22/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $34.00 -> $27.00 | N/A | View details for BTIG Research rating of Instructure (NYSE:INST) on 7/22/2024 |
CRWD CrowdStrike | $256.16
+0.8% | 7/22/2024 | Downgraded by | BTIG Research | Analyst G. Powell | Buy -> Neutral | | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 7/22/2024 |
AGYS Agilysys | $110.70
+2.4% | 7/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $95.00 -> $118.00 | Low | View details for BTIG Research rating of Agilysys (NASDAQ:AGYS) on 7/19/2024 |
FOR Forestar Group | $31.96
+3.1% | 7/19/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $41.00 -> $37.00 | Low | View details for BTIG Research rating of Forestar Group (NYSE:FOR) on 7/19/2024 |
ARI Apollo Commercial Real Estate Finance | $10.72
+0.9% | 7/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Apollo Commercial Real Estate Finance (NYSE:ARI) on 7/19/2024 |
CMTG Claros Mortgage Trust | $9.61
+1.4% | 7/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Claros Mortgage Trust (NYSE:CMTG) on 7/19/2024 |
RC Ready Capital | $9.32
+2.1% | 7/19/2024 | Initiated by | BTIG Research | Analyst S. Barcomb | Strong-Buy -> Neutral | | Low | View details for BTIG Research rating of Ready Capital (NYSE:RC) on 7/19/2024 |
ACRE Ares Commercial Real Estate | $7.74
+2.2% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Neutral | | Low | View details for BTIG Research rating of Ares Commercial Real Estate (NYSE:ACRE) on 7/19/2024 |
BRSP BrightSpire Capital | $6.37
+1.0% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Neutral | | Low | View details for BTIG Research rating of BrightSpire Capital (NYSE:BRSP) on 7/19/2024 |
BXMT Blackstone Mortgage Trust | $17.60
+1.0% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $23.00 | Low | View details for BTIG Research rating of Blackstone Mortgage Trust (NYSE:BXMT) on 7/19/2024 |
FBRT Franklin BSP Realty Trust | $13.85
+1.0% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $16.00 | Low | View details for BTIG Research rating of Franklin BSP Realty Trust (NYSE:FBRT) on 7/19/2024 |
KREF KKR Real Estate Finance Trust | $11.42
+1.2% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $11.50 | Low | View details for BTIG Research rating of KKR Real Estate Finance Trust (NYSE:KREF) on 7/19/2024 |
LADR Ladder Capital | $12.20
+0.5% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $13.50 | Low | View details for BTIG Research rating of Ladder Capital (NYSE:LADR) on 7/19/2024 |
STWD Starwood Property Trust | $19.90
+1.4% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $24.00 | Low | View details for BTIG Research rating of Starwood Property Trust (NYSE:STWD) on 7/19/2024 |
TRTX TPG RE Finance Trust | $9.00
+0.4% | 7/19/2024 | Reiterated by | BTIG Research | Analyst T. Catherwood | Buy | $11.00 | Low | View details for BTIG Research rating of TPG RE Finance Trust (NYSE:TRTX) on 7/19/2024 |
RZLT Rezolute | $4.68
| 7/17/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $13.00 | Low | View details for BTIG Research rating of Rezolute (NASDAQ:RZLT) on 7/17/2024 |
VCEL Vericel | $52.32
+1.2% | 7/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $56.00 -> $55.00 | Low | View details for BTIG Research rating of Vericel (NASDAQ:VCEL) on 7/15/2024 |
SYK Stryker | $331.67
+1.3% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $369.00 -> $372.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 7/15/2024 |
STAA STAAR Surgical | $40.07
-1.5% | 7/15/2024 | Target Raised by | BTIG Research | Analyst R. Zimmerman | Buy -> Buy | $46.00 -> $53.00 | Low | View details for BTIG Research rating of STAAR Surgical (NASDAQ:STAA) on 7/15/2024 |
RXST RxSight | $44.50
-1.8% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $72.00 -> $73.00 | Low | View details for BTIG Research rating of RxSight (NASDAQ:RXST) on 7/15/2024 |
PEN Penumbra | $178.41
-6.1% | 7/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $265.00 -> $232.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 7/15/2024 |
ISRG Intuitive Surgical | $441.30
+1.0% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $451.00 -> $459.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 7/15/2024 |
HUMA Humacyte | $7.94
-2.6% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $8.00 -> $11.00 | Low | View details for BTIG Research rating of Humacyte (NASDAQ:HUMA) on 7/15/2024 |
GMED Globus Medical | $71.89
+0.2% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $72.00 -> $75.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 7/15/2024 |
GKOS Glaukos | $119.82
+1.8% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $112.00 -> $131.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 7/15/2024 |
BSX Boston Scientific | $74.95
+0.9% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $80.00 -> $84.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 7/15/2024 |
ALC Alcon | $93.37
+1.7% | 7/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $92.00 -> $96.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 7/15/2024 |
CVNA Carvana | $132.72
+6.9% | 7/12/2024 | Initiated by | BTIG Research | Analyst M. Fong | Buy | $155.00 | Low | View details for BTIG Research rating of Carvana (NYSE:CVNA) on 7/12/2024 |
JILL J.Jill | $38.77
+2.6% | 7/10/2024 | Initiated by | BTIG Research | Analyst J. Stichter | Buy | $44.00 | Low | View details for BTIG Research rating of J.Jill (NYSE:JILL) on 7/10/2024 |
IDYA IDEAYA Biosciences | $42.39
+0.2% | 7/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $55.00 -> $62.00 | Low | View details for BTIG Research rating of IDEAYA Biosciences (NASDAQ:IDYA) on 7/9/2024 |
Automatic Income (from home) (Ad) Everyone’s talking about this new income hack that could generate triple digit returns on your money.
But here’s the best part… Watch this short video |
VEEV Veeva Systems | $192.55
+3.2% | 7/9/2024 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $240.00 | Low | View details for BTIG Research rating of Veeva Systems (NYSE:VEEV) on 7/9/2024 |
JSPR Jasper Therapeutics | $20.59
-3.2% | 7/8/2024 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $90.00 | Low | View details for BTIG Research rating of Jasper Therapeutics (NASDAQ:JSPR) on 7/8/2024 |
MGM MGM Resorts International | $41.84
+1.0% | 7/3/2024 | Initiated by | BTIG Research | Analyst C. Lampen | Buy | $52.00 | Low | View details for BTIG Research rating of MGM Resorts International (NYSE:MGM) on 7/3/2024 |
GMAB Genmab A/S | $28.38
+0.9% | 6/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $46.00 -> $47.00 | Low | View details for BTIG Research rating of Genmab A/S (NASDAQ:GMAB) on 6/27/2024 |
WGS GeneDx | $33.53
+2.5% | 6/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $35.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 6/26/2024 |
CORZ Core Scientific | $10.21
+8.5% | 6/26/2024 | Target Raised by | BTIG Research | Analyst G. Lewis | Buy -> Buy | $10.00 -> $15.00 | Low | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 6/26/2024 |
DNA Ginkgo Bioworks | $0.37
+8.8% | 6/26/2024 | Target Lowered by | BTIG Research | Analyst M. Massaro | Sell -> Sell | $0.50 -> $0.20 | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 6/26/2024 |
GD General Dynamics | $290.40
-0.2% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $345.00 | Low | View details for BTIG Research rating of General Dynamics (NYSE:GD) on 6/26/2024 |
HWM Howmet Aerospace | $82.68
+0.4% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $95.00 | Low | View details for BTIG Research rating of Howmet Aerospace (NYSE:HWM) on 6/26/2024 |
KTOS Kratos Defense & Security Solutions | $22.66
+1.8% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Neutral | | Low | View details for BTIG Research rating of Kratos Defense & Security Solutions (NASDAQ:KTOS) on 6/26/2024 |
RKLB Rocket Lab USA | $5.40
+2.9% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Neutral | | Low | View details for BTIG Research rating of Rocket Lab USA (NASDAQ:RKLB) on 6/26/2024 |
DRS Leonardo DRS | $28.50
+1.2% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $30.00 | Low | View details for BTIG Research rating of Leonardo DRS (NASDAQ:DRS) on 6/26/2024 |
NOC Northrop Grumman | $480.30
+2.1% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $565.00 | Low | View details for BTIG Research rating of Northrop Grumman (NYSE:NOC) on 6/26/2024 |
CRS Carpenter Technology | $140.78
+4.5% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $120.00 | Low | View details for BTIG Research rating of Carpenter Technology (NYSE:CRS) on 6/26/2024 |
BWXT BWX Technologies | $99.14
+0.4% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $110.00 | Low | View details for BTIG Research rating of BWX Technologies (NYSE:BWXT) on 6/26/2024 |
ATI ATI | $65.54
+2.0% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $70.00 | Low | View details for BTIG Research rating of ATI (NYSE:ATI) on 6/26/2024 |
AVAV AeroVironment | $173.82
+2.3% | 6/26/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $255.00 -> $255.00 | Low | View details for BTIG Research rating of AeroVironment (NASDAQ:AVAV) on 6/26/2024 |
EXAS Exact Sciences | $45.30
-6.3% | 6/26/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $80.00 -> $70.00 | Low | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 6/26/2024 |
GLNG Golar LNG | $35.24
-0.3% | 6/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $36.00 -> $45.00 | Low | View details for BTIG Research rating of Golar LNG (NASDAQ:GLNG) on 6/25/2024 |
DECK Deckers Outdoor | $894.90
+6.3% | 6/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $1,120.00 -> $1,200.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 6/25/2024 |
XAIR Beyond Air | $0.64
+1.6% | 6/25/2024 | Downgraded by | BTIG Research | Analyst M. Thibault | Buy -> Neutral | | Low | View details for BTIG Research rating of Beyond Air (NASDAQ:XAIR) on 6/25/2024 |
BTSG BrightSpring Health Services | $12.33
+2.0% | 6/21/2024 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $15.00 | Low | View details for BTIG Research rating of BrightSpring Health Services (NASDAQ:BTSG) on 6/21/2024 |
LEN Lennar | $176.71
+3.2% | 6/20/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $177.00 -> $175.00 | Low | View details for BTIG Research rating of Lennar (NYSE:LEN) on 6/20/2024 |
OVID Ovid Therapeutics | $1.06
| 6/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $11.00 -> $5.00 | Low | View details for BTIG Research rating of Ovid Therapeutics (NASDAQ:OVID) on 6/18/2024 |
AVTE Aerovate Therapeutics | $2.01
+4.7% | 6/17/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of Aerovate Therapeutics (NASDAQ:AVTE) on 6/17/2024 |
STTK Shattuck Labs | $4.41
-0.5% | 6/17/2024 | Downgraded by | BTIG Research | Analyst K. Pohlman | Buy -> Neutral | | Low | View details for BTIG Research rating of Shattuck Labs (NASDAQ:STTK) on 6/17/2024 |
STAA STAAR Surgical | $40.07
-1.5% | 6/11/2024 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Buy | $46.00 | Low | View details for BTIG Research rating of STAAR Surgical (NASDAQ:STAA) on 6/11/2024 |
SOFI SoFi Technologies | $7.41
+1.9% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of SoFi Technologies (NASDAQ:SOFI) on 6/7/2024 |
UPST Upstart | $26.11
+1.4% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Sell | $14.00 | Low | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 6/7/2024 |
SYF Synchrony Financial | $50.78
+0.8% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $60.00 | Low | View details for BTIG Research rating of Synchrony Financial (NYSE:SYF) on 6/7/2024 |
UPBD Upbound Group | $37.16
+4.7% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $45.00 | Low | View details for BTIG Research rating of Upbound Group (NASDAQ:UPBD) on 6/7/2024 |
RM Regional Management | $31.73
-0.3% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Regional Management (NYSE:RM) on 6/7/2024 |
PRG PROG | $43.94
+3.8% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of PROG (NYSE:PRG) on 6/7/2024 |
LPRO Open Lending | $6.34
+3.3% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Open Lending (NASDAQ:LPRO) on 6/7/2024 |
OMF OneMain | $53.09
+1.2% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of OneMain (NYSE:OMF) on 6/7/2024 |
LC LendingClub | $10.86
+0.6% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $12.00 | Low | View details for BTIG Research rating of LendingClub (NYSE:LC) on 6/7/2024 |
FCFS FirstCash | $111.87
-0.3% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of FirstCash (NASDAQ:FCFS) on 6/7/2024 |
DFS Discover Financial Services | $142.29
+0.5% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Discover Financial Services (NYSE:DFS) on 6/7/2024 |
AAN Aaron's | $9.96
+0.2% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Aaron’s (NYSE:AAN) on 6/7/2024 |
COF Capital One Financial | $149.39
+0.9% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Capital One Financial (NYSE:COF) on 6/7/2024 |
BFH Bread Financial | $55.01
+5.1% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Bread Financial (NYSE:BFH) on 6/7/2024 |
ATLC Atlanticus | $35.56
-1.2% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $45.00 | Low | View details for BTIG Research rating of Atlanticus (NASDAQ:ATLC) on 6/7/2024 |
CRMT America's Car-Mart | $68.57
+2.3% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of America’s Car-Mart (NASDAQ:CRMT) on 6/7/2024 |
AXP American Express | $245.88
+2.4% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of American Express (NYSE:AXP) on 6/7/2024 |
ALLY Ally Financial | $43.98
+1.5% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $51.00 | Low | View details for BTIG Research rating of Ally Financial (NYSE:ALLY) on 6/7/2024 |
AFRM Affirm | $27.10
+2.4% | 6/7/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Neutral | | Low | View details for BTIG Research rating of Affirm (NASDAQ:AFRM) on 6/7/2024 |
BE Bloom Energy | $14.51
+0.2% | 6/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $21.00 | Low | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 6/6/2024 |
FIP FTAI Infrastructure | $9.97
+1.8% | 6/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $10.00 -> $11.00 | Low | View details for BTIG Research rating of FTAI Infrastructure (NASDAQ:FIP) on 6/6/2024 |
CORZ Core Scientific | $10.21
+8.5% | 6/6/2024 | Target Raised by | BTIG Research | Analyst G. Lewis | Buy -> Buy | $8.00 -> $10.00 | Low | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 6/6/2024 |
SHOO Steven Madden | $44.02
+3.2% | 6/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $50.00 -> $53.00 | Low | View details for BTIG Research rating of Steven Madden (NASDAQ:SHOO) on 6/6/2024 |
This TSLA short trade is on a nine win hot streak (Ad) Most Tesla Shareholders are disappointed in the stock's performance in 2024.
Year to date, it's down 30%...
And things don’t seem to be getting better.
That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity…
In fact, he has not lost a single trade on Tesla this year.
As of this mailing he’s 9 for 9 with incredible wins under his belt.
Just see for yourself. But I can promise that you’ll see all the details for yourself here. |
BOOT Boot Barn | $129.81
+6.2% | 6/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $125.00 -> $150.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 6/5/2024 |
GWRE Guidewire Software | $147.98
+2.3% | 6/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $135.00 -> $140.00 | Low | View details for BTIG Research rating of Guidewire Software (NYSE:GWRE) on 6/5/2024 |
CRWD CrowdStrike | $256.16
+0.8% | 6/5/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $432.00 -> $402.00 | Low | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 6/5/2024 |
GTLB GitLab | $53.37
-0.1% | 6/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $71.00 -> $58.00 | Low | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 6/4/2024 |
IMXI International Money Express | $21.49
+2.3% | 6/3/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $25.00 | Low | View details for BTIG Research rating of International Money Express (NASDAQ:IMXI) on 6/3/2024 |
SMRT SmartRent | $2.48
+2.1% | 6/3/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $4.30 -> $4.00 | Low | View details for BTIG Research rating of SmartRent (NYSE:SMRT) on 6/3/2024 |
BRZE Braze | $42.90
+3.1% | 5/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $68.00 -> $62.00 | Low | View details for BTIG Research rating of Braze (NASDAQ:BRZE) on 5/31/2024 |
S SentinelOne | $23.03
-0.3% | 5/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $30.00 -> $23.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 5/31/2024 |
ZS Zscaler | $181.36
-0.4% | 5/31/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $258.00 -> $220.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 5/31/2024 |
ACIU AC Immune | $3.91
| 5/31/2024 | Initiated by | BTIG Research | Analyst T. Shrader | Buy | $8.00 | Low | View details for BTIG Research rating of AC Immune (NASDAQ:ACIU) on 5/31/2024 |
GLNG Golar LNG | $35.24
-0.3% | 5/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $36.00 | Low | View details for BTIG Research rating of Golar LNG (NASDAQ:GLNG) on 5/29/2024 |
CORZ Core Scientific | $10.21
+8.5% | 5/29/2024 | Upgraded by | BTIG Research | Analyst G. Lewis | Neutral -> Buy | $8.00 | Low | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 5/29/2024 |
GMED Globus Medical | $71.89
+0.2% | 5/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $63.00 -> $72.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 5/29/2024 |
DECK Deckers Outdoor | $894.90
+6.3% | 5/24/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $1,020.00 -> $1,120.00 | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 5/24/2024 |
MGNX MacroGenics | $5.55
+0.9% | 5/24/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $9.00 | Low | View details for BTIG Research rating of MacroGenics (NASDAQ:MGNX) on 5/24/2024 |
ENS EnerSys | $109.91
+1.5% | 5/24/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | Low | View details for BTIG Research rating of EnerSys (NYSE:ENS) on 5/24/2024 |
TYL Tyler Technologies | $590.65
+4.7% | 5/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $515.00 -> $550.00 | Low | View details for BTIG Research rating of Tyler Technologies (NYSE:TYL) on 5/22/2024 |
EXPE Expedia Group | $125.87
+0.8% | 5/21/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $175.00 -> $150.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 5/21/2024 |
ABVX ABIVAX Société Anonyme | $11.86
+0.3% | 5/20/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $43.00 | Low | View details for BTIG Research rating of ABIVAX Société Anonyme (NASDAQ:ABVX) on 5/20/2024 |
DRI Darden Restaurants | $142.27
+0.3% | 5/17/2024 | Upgraded by | BTIG Research | Analyst P. Saleh | Neutral -> Buy | $175.00 | Low | View details for BTIG Research rating of Darden Restaurants (NYSE:DRI) on 5/17/2024 |
XTNT Xtant Medical | $0.74
+1.4% | 5/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $2.00 -> $3.00 | N/A | View details for BTIG Research rating of Xtant Medical (NYSEAMERICAN:XTNT) on 5/16/2024 |
BNGO Bionano Genomics | $0.63
+5.0% | 5/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $3.00 -> $2.00 | Low | View details for BTIG Research rating of Bionano Genomics (NASDAQ:BNGO) on 5/16/2024 |
TCRX TScan Therapeutics | $7.27
+1.3% | 5/16/2024 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $12.00 | Low | View details for BTIG Research rating of TScan Therapeutics (NASDAQ:TCRX) on 5/16/2024 |
FLUT Flutter Entertainment | $198.63
+1.8% | 5/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $242.00 -> $245.00 | Low | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 5/15/2024 |
BOOT Boot Barn | $129.81
+6.2% | 5/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $127.00 -> $125.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 5/15/2024 |
DNA Ginkgo Bioworks | $0.37
+8.8% | 5/15/2024 | Downgraded by | BTIG Research | Analyst M. Massaro | Neutral -> Sell | | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 5/15/2024 |
SFL SFL | $11.80
-0.8% | 5/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $15.00 -> $16.00 | Low | View details for BTIG Research rating of SFL (NYSE:SFL) on 5/14/2024 |
AKYA Akoya Biosciences | $2.46
+0.8% | 5/14/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $9.00 -> $6.00 | Low | View details for BTIG Research rating of Akoya Biosciences (NASDAQ:AKYA) on 5/14/2024 |
NTRA Natera | $102.67
+0.5% | 5/13/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $125.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 5/13/2024 |
RBLX Roblox | $40.51
-0.1% | 5/10/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $54.00 -> $46.00 | Low | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 5/10/2024 |
SYRE Spyre Therapeutics | $31.47
+4.5% | 5/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $32.00 -> $40.00 | Low | View details for BTIG Research rating of Spyre Therapeutics (NASDAQ:SYRE) on 5/10/2024 |
TDW Tidewater | $98.44
-1.6% | 5/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $130.00 | Low | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 5/10/2024 |
PGNY Progyny | $29.14
+1.9% | 5/10/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $50.00 -> $41.00 | Low | View details for BTIG Research rating of Progyny (NASDAQ:PGNY) on 5/10/2024 |
RANI Rani Therapeutics | $2.93
+2.1% | 5/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $14.00 | Low | View details for BTIG Research rating of Rani Therapeutics (NASDAQ:RANI) on 5/9/2024 |
DCGO DocGo | $3.74
+5.4% | 5/9/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $11.00 -> $7.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 5/9/2024 |
EXAS Exact Sciences | $45.30
-6.3% | 5/9/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $85.00 -> $80.00 | Low | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 5/9/2024 |
APP AppLovin | $77.53
+1.8% | 5/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $87.00 -> $100.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 5/9/2024 |
INTA Intapp | $37.07
+0.8% | 5/8/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $55.00 -> $50.00 | Low | View details for BTIG Research rating of Intapp (NASDAQ:INTA) on 5/8/2024 |
FLYW Flywire | $18.52
+2.3% | 5/8/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $34.00 -> $27.00 | Low | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 5/8/2024 |
GMED Globus Medical | $71.89
+0.2% | 5/8/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $60.00 -> $63.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 5/8/2024 |
LULU Lululemon Athletica | $253.50
+2.5% | 5/8/2024 | Initiated by | BTIG Research | Analyst J. Stichter | Buy | $425.00 | Low | View details for BTIG Research rating of Lululemon Athletica (NASDAQ:LULU) on 5/8/2024 |
TMCI Treace Medical Concepts | $7.72
-1.4% | 5/8/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Buy -> Neutral | | Low | View details for BTIG Research rating of Treace Medical Concepts (NASDAQ:TMCI) on 5/8/2024 |
RXST RxSight | $44.50
-1.8% | 5/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $61.00 -> $72.00 | Low | View details for BTIG Research rating of RxSight (NASDAQ:RXST) on 5/7/2024 |
SHAK Shake Shack | $80.11
+1.6% | 5/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $120.00 -> $125.00 | Low | View details for BTIG Research rating of Shake Shack (NYSE:SHAK) on 5/6/2024 |
LYRA Lyra Therapeutics | $0.31
| 5/6/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | N/A | View details for BTIG Research rating of Lyra Therapeutics (NASDAQ:LYRA) on 5/6/2024 |
DKNG DraftKings | $36.30
+1.5% | 5/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $53.00 -> $55.00 | Low | View details for BTIG Research rating of DraftKings (NASDAQ:DKNG) on 5/6/2024 |
TXRH Texas Roadhouse | $169.38
+2.0% | 5/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $155.00 -> $175.00 | Low | View details for BTIG Research rating of Texas Roadhouse (NASDAQ:TXRH) on 5/3/2024 |
SPT Sprout Social | $38.92
+1.9% | 5/3/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sprout Social (NASDAQ:SPT) on 5/3/2024 |
GKOS Glaukos | $119.82
+1.8% | 5/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $107.00 -> $112.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 5/2/2024 |
NEO NeoGenomics | $14.88
-1.3% | 5/2/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $21.00 | Low | View details for BTIG Research rating of NeoGenomics (NASDAQ:NEO) on 5/2/2024 |
Prepare for a Recession Unlike Any Other (Ad) Dave Ramsey Is Dangerously Wrong And Here’s Why>>
Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air:
“Am I worried about this? Absolutely not.”
Frankly, I've never seen someone so confident in being wrong…
Because what’s happening to the US Dollar is not something you should “keep an eye on”…
But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE |
QTWO Q2 | $68.99
+3.8% | 5/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $48.00 -> $60.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 5/2/2024 |
ETSY Etsy | $62.27
+3.0% | 5/2/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $87.00 -> $78.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 5/2/2024 |
UPWK Upwork | $11.35
-0.6% | 5/2/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $16.00 | Low | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 5/2/2024 |
SBUX Starbucks | $74.05
+1.0% | 5/1/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $115.00 -> $100.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 5/1/2024 |
SYK Stryker | $331.67
+1.3% | 5/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $366.00 -> $369.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 5/1/2024 |
DPZ Domino's Pizza | $417.45
-1.8% | 4/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $515.00 -> $580.00 | Low | View details for BTIG Research rating of Domino’s Pizza (NYSE:DPZ) on 4/30/2024 |
WGS GeneDx | $33.53
+2.5% | 4/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $15.00 -> $19.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 4/30/2024 |
STC Stewart Information Services | $73.26
+1.3% | 4/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $68.00 -> $70.00 | Low | View details for BTIG Research rating of Stewart Information Services (NYSE:STC) on 4/29/2024 |
BOOT Boot Barn | $129.81
+6.2% | 4/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $127.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 4/29/2024 |
CMG Chipotle Mexican Grill | $49.81
-2.0% | 4/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $67.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 4/25/2024 |
HCP HashiCorp | $33.59
+0.1% | 4/24/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 4/24/2024 |
LFMD LifeMD | $7.03
+1.0% | 4/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $13.00 -> $14.00 | Low | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 4/23/2024 |
WGS GeneDx | $33.53
+2.5% | 4/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $15.00 | Low | View details for BTIG Research rating of GeneDx (NASDAQ:WGS) on 4/22/2024 |
PINE Alpine Income Property Trust | $17.20
+0.2% | 4/22/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $23.00 -> $19.00 | Low | View details for BTIG Research rating of Alpine Income Property Trust (NYSE:PINE) on 4/22/2024 |
ISRG Intuitive Surgical | $441.30
+1.0% | 4/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $412.00 -> $421.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 4/19/2024 |
FVRR Fiverr International | $22.72
+2.8% | 4/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $30.00 -> $28.00 | Low | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 4/18/2024 |
EFC Ellington Financial | $12.89
+1.4% | 4/18/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.50 -> $13.50 | Low | View details for BTIG Research rating of Ellington Financial (NYSE:EFC) on 4/18/2024 |
FIP FTAI Infrastructure | $9.97
+1.8% | 4/18/2024 | Initiated by | BTIG Research | - | Buy | $10.00 | Low | View details for BTIG Research rating of FTAI Infrastructure (NASDAQ:FIP) on 4/18/2024 |
CGEM Cullinan Therapeutics | $20.16
+1.3% | 4/17/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for BTIG Research rating of Cullinan Therapeutics (NASDAQ:CGEM) on 4/17/2024 |
BXMT Blackstone Mortgage Trust | $17.60
+1.0% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $22.00 | N/A | View details for BTIG Research rating of Blackstone Mortgage Trust (NYSE:BXMT) on 4/17/2024 |
FBRT Franklin BSP Realty Trust | $13.85
+1.0% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $15.00 -> $14.00 | N/A | View details for BTIG Research rating of Franklin BSP Realty Trust (NYSE:FBRT) on 4/17/2024 |
RC Ready Capital | $9.32
+2.1% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $12.00 -> $10.00 | N/A | View details for BTIG Research rating of Ready Capital (NYSE:RC) on 4/17/2024 |
STWD Starwood Property Trust | $19.90
+1.4% | 4/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $24.00 -> $23.00 | N/A | View details for BTIG Research rating of Starwood Property Trust (NYSE:STWD) on 4/17/2024 |
XNCR Xencor | $21.65
+1.8% | 4/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $56.00 -> $38.00 | Low | View details for BTIG Research rating of Xencor (NASDAQ:XNCR) on 4/16/2024 |
DHI D.R. Horton | $176.99
+2.5% | 4/16/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $174.00 -> $169.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 4/16/2024 |
HAFN Hafnia | $7.55
-0.5% | 4/12/2024 | Initiated by | BTIG Research | - | Buy | $10.00 | Low | View details for BTIG Research rating of Hafnia (NYSE:HAFN) on 4/12/2024 |
TBPH Theravance Biopharma | $10.25
+0.4% | 4/12/2024 | Initiated by | BTIG Research | - | Buy | $21.00 | Low | View details for BTIG Research rating of Theravance Biopharma (NASDAQ:TBPH) on 4/12/2024 |
CARM Carisma Therapeutics | $1.18
+9.3% | 4/11/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Carisma Therapeutics (NASDAQ:CARM) on 4/11/2024 |
RCEL AVITA Medical | $10.13
-0.7% | 4/11/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of AVITA Medical (NASDAQ:RCEL) on 4/11/2024 |
DCGO DocGo | $3.74
+5.4% | 4/10/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $13.00 -> $11.00 | Low | View details for BTIG Research rating of DocGo (NASDAQ:DCGO) on 4/10/2024 |
APP AppLovin | $77.53
+1.8% | 4/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $87.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 4/9/2024 |
OM Outset Medical | $3.74
+0.8% | 4/8/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Outset Medical (NASDAQ:OM) on 4/8/2024 |
MSTR MicroStrategy | $1,752.71
+9.1% | 4/5/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $780.00 -> $1,800.00 | Low | View details for BTIG Research rating of MicroStrategy (NASDAQ:MSTR) on 4/5/2024 |
ADPT Adaptive Biotechnologies | $4.51
+4.2% | 4/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $6.00 -> $5.00 | Low | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 4/4/2024 |
RVLV Revolve Group | $18.46
+3.6% | 4/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $22.00 -> $24.00 | Low | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 4/3/2024 |
KEX Kirby | $119.45
+1.3% | 4/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $115.00 | Low | View details for BTIG Research rating of Kirby (NYSE:KEX) on 4/3/2024 |
SHCR Sharecare | $1.38
| 4/1/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Sharecare (NASDAQ:SHCR) on 4/1/2024 |
PIII P3 Health Partners | $0.62
+1.6% | 4/1/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of P3 Health Partners (NASDAQ:PIII) on 4/1/2024 |
CMG Chipotle Mexican Grill | $49.81
-2.0% | 3/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $55.00 -> $65.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 3/28/2024 |
CYBR CyberArk Software | $257.68
+0.3% | 3/28/2024 | Initiated by | BTIG Research | - | Buy | $317.00 | Low | View details for BTIG Research rating of CyberArk Software (NASDAQ:CYBR) on 3/28/2024 |
OTLK Outlook Therapeutics | $8.56
+2.6% | 3/27/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $50.00 | Low | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 3/27/2024 |
VKTX Viking Therapeutics | $65.98
+2.0% | 3/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $125.00 | Low | View details for BTIG Research rating of Viking Therapeutics (NASDAQ:VKTX) on 3/26/2024 |
NUVB Nuvation Bio | $3.73
+1.1% | 3/26/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $5.00 | Low | View details for BTIG Research rating of Nuvation Bio (NYSE:NUVB) on 3/26/2024 |
MASI Masimo | $108.99
-0.7% | 3/25/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $145.00 -> $166.00 | Low | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 3/25/2024 |
PZZA Papa John's International | $40.93
-0.1% | 3/22/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Papa John’s International (NASDAQ:PZZA) on 3/22/2024 |
SFL SFL | $11.80
-0.8% | 3/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $13.00 -> $15.00 | Low | View details for BTIG Research rating of SFL (NYSE:SFL) on 3/20/2024 |
HQY HealthEquity | $80.98
+1.5% | 3/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $100.00 -> $110.00 | Low | View details for BTIG Research rating of HealthEquity (NASDAQ:HQY) on 3/20/2024 |
JANX Janux Therapeutics | $43.99
+2.9% | 3/21/2024 | Initiated by | BTIG Research | - | Buy | $62.00 | Low | View details for BTIG Research rating of Janux Therapeutics (NASDAQ:JANX) on 3/21/2024 |
USFD US Foods | $52.69
+2.4% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $52.00 -> $62.00 | Low | View details for BTIG Research rating of US Foods (NYSE:USFD) on 3/19/2024 |
CLSK CleanSpark | $17.12
+5.8% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $12.00 -> $22.00 | Low | View details for BTIG Research rating of CleanSpark (NASDAQ:CLSK) on 3/19/2024 |
Prepare for a Recession Unlike Any Other (Ad) Dave Ramsey Is Dangerously Wrong And Here’s Why>>
Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air:
“Am I worried about this? Absolutely not.”
Frankly, I've never seen someone so confident in being wrong…
Because what’s happening to the US Dollar is not something you should “keep an eye on”…
But instead, is an imminent threat you should get ahead of right NOW. GET THE FREE GUIDE |
TDW Tidewater | $98.44
-1.6% | 3/19/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $90.00 -> $110.00 | Low | View details for BTIG Research rating of Tidewater (NYSE:TDW) on 3/19/2024 |
MXCT MaxCyte | $4.79
+3.7% | 3/13/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $10.00 -> $8.00 | Low | View details for BTIG Research rating of MaxCyte (NASDAQ:MXCT) on 3/13/2024 |
SHAK Shake Shack | $80.11
+1.6% | 3/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $120.00 | Low | View details for BTIG Research rating of Shake Shack (NYSE:SHAK) on 3/14/2024 |
LFMD LifeMD | $7.03
+1.0% | 3/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $13.00 | N/A | View details for BTIG Research rating of LifeMD (NASDAQ:LFMD) on 3/15/2024 |
VKTX Viking Therapeutics | $65.98
+2.0% | 3/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $86.00 -> $100.00 | Low | View details for BTIG Research rating of Viking Therapeutics (NASDAQ:VKTX) on 3/15/2024 |
GMED Globus Medical | $71.89
+0.2% | 3/18/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $60.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 3/18/2024 |
BTDR Bitdeer Technologies Group | $9.87
+2.3% | 3/13/2024 | Initiated by | BTIG Research | - | Buy | $15.00 | Low | View details for BTIG Research rating of Bitdeer Technologies Group (NASDAQ:BTDR) on 3/13/2024 |
TKNO Alpha Teknova | $4.08
+14.9% | 3/12/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Alpha Teknova (NASDAQ:TKNO) on 3/12/2024 |
IDYA IDEAYA Biosciences | $42.39
+0.2% | 3/8/2024 | Initiated by | BTIG Research | - | Buy | $55.00 | Low | View details for BTIG Research rating of IDEAYA Biosciences (NASDAQ:IDYA) on 3/8/2024 |
GNL Global Net Lease | $8.96
+2.6% | 3/8/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Global Net Lease (NYSE:GNL) on 3/8/2024 |
ZLDPF Zealand Pharma A/S | $129.24
-4.7% | 3/7/2024 | Initiated by | BTIG Research | - | Buy | | Low | View details for BTIG Research rating of Zealand Pharma A/S (OTCMKTS:ZLDPF) on 3/7/2024 |
SOPH SOPHiA GENETICS | $4.65
+0.4% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $8.00 | Low | View details for BTIG Research rating of SOPHiA GENETICS (NASDAQ:SOPH) on 3/6/2024 |
CRWD CrowdStrike | $256.16
+0.8% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $322.00 -> $432.00 | N/A | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 3/6/2024 |
HCP HashiCorp | $33.59
+0.1% | 3/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $25.00 -> $27.00 | Low | View details for BTIG Research rating of HashiCorp (NASDAQ:HCP) on 3/6/2024 |
MGNX MacroGenics | $5.55
+0.9% | 3/4/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $12.00 -> $24.00 | Low | View details for BTIG Research rating of MacroGenics (NASDAQ:MGNX) on 3/4/2024 |
COMP Compass | $4.44
+2.5% | 2/29/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $4.50 -> $4.30 | Low | View details for BTIG Research rating of Compass (NYSE:COMP) on 2/29/2024 |
MRSN Mersana Therapeutics | $2.10
+6.1% | 2/29/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $6.00 | Low | View details for BTIG Research rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
BMBL Bumble | $9.13
-0.4% | 2/28/2024 | Target Lowered by | BTIG Research | - | Buy | $20.00 -> $15.00 | Low | View details for BTIG Research rating of Bumble (NASDAQ:BMBL) on 2/28/2024 |
ANAB AnaptysBio | $37.06
-0.5% | 2/26/2024 | Initiated by | BTIG Research | - | Buy | $55.00 | Low | View details for BTIG Research rating of AnaptysBio (NASDAQ:ANAB) on 2/26/2024 |
TTD Trade Desk | $92.43
+1.7% | 2/23/2024 | Target Raised by | BTIG Research | - | Buy | $91.00 -> $98.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 2/23/2024 |
PLL Piedmont Lithium | $10.67
+2.7% | 2/23/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Piedmont Lithium (NASDAQ:PLL) on 2/23/2024 |
ETSY Etsy | $62.27
+3.0% | 2/22/2024 | Target Lowered by | BTIG Research | - | Buy | $90.00 -> $87.00 | Low | View details for BTIG Research rating of Etsy (NASDAQ:ETSY) on 2/22/2024 |
UBER Uber Technologies | $64.40
-2.0% | 2/22/2024 | Target Raised by | BTIG Research | - | Buy | $80.00 -> $90.00 | Low | View details for BTIG Research rating of Uber Technologies (NYSE:UBER) on 2/22/2024 |
FLYX flyExclusive | $4.28
-2.1% | 2/22/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of flyExclusive (NYSE:FLYX) on 2/22/2024 |
GHLD Guild | $14.54
+2.6% | 2/21/2024 | Initiated by | BTIG Research | - | Buy | $18.00 | Low | View details for BTIG Research rating of Guild (NYSE:GHLD) on 2/21/2024 |
IQV IQVIA | $239.67
+3.2% | 2/13/2024 | Initiated by | BTIG Research | - | Buy | $285.00 | Low | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 2/13/2024 |
PYXS Pyxis Oncology | $3.88
+0.8% | 2/9/2024 | Initiated by | BTIG Research | - | Buy | $8.00 | Low | View details for BTIG Research rating of Pyxis Oncology (NASDAQ:PYXS) on 2/9/2024 |
CMG Chipotle Mexican Grill | $49.81
-2.0% | 2/7/2024 | Target Raised by | BTIG Research | - | Buy | $53.00 -> $55.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 2/7/2024 |
PCTY Paylocity | $149.43
+1.2% | 2/6/2024 | Initiated by | BTIG Research | - | Buy | $200.00 | Low | View details for BTIG Research rating of Paylocity (NASDAQ:PCTY) on 2/6/2024 |
PYCR Paycor HCM | $12.87
-0.2% | 2/6/2024 | Initiated by | BTIG Research | - | Buy | $26.00 | Low | View details for BTIG Research rating of Paycor HCM (NASDAQ:PYCR) on 2/6/2024 |
PAYC Paycom Software | $164.03
+0.7% | 2/6/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Paycom Software (NYSE:PAYC) on 2/6/2024 |
MCD McDonald's | $252.00
+0.2% | 2/6/2024 | Downgraded by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of McDonald’s (NYSE:MCD) on 2/6/2024 |
BOOT Boot Barn | $129.81
+6.2% | 2/1/2024 | Target Lowered by | BTIG Research | - | Buy | $102.00 -> $100.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 2/1/2024 |
SBUX Starbucks | $74.05
+1.0% | 1/31/2024 | Target Lowered by | BTIG Research | - | Buy | $125.00 -> $115.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 1/31/2024 |
SQ Block | $60.16
-2.3% | 1/30/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $85.00 | Low | View details for BTIG Research rating of Block (NYSE:SQ) on 1/30/2024 |
PNST Pinstripes | $2.30
+1.8% | 1/29/2024 | Initiated by | BTIG Research | - | Buy | $6.00 | Low | View details for BTIG Research rating of Pinstripes (NYSE:PNST) on 1/29/2024 |
CCSI Consensus Cloud Solutions | $22.56
+0.3% | 1/26/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 1/26/2024 |
BE Bloom Energy | $14.51
+0.2% | 1/25/2024 | Initiated by | BTIG Research | - | Buy | $21.00 | Low | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 1/25/2024 |
MDAI Spectral AI | $1.79
+1.1% | 1/23/2024 | Initiated by | BTIG Research | - | Buy | $4.00 | Low | View details for BTIG Research rating of Spectral AI (NASDAQ:MDAI) on 1/23/2024 |
FLYX flyExclusive | $4.28
-2.1% | 1/23/2024 | Initiated by | BTIG Research | - | Buy | $9.00 | Low | View details for BTIG Research rating of flyExclusive (NYSE:FLYX) on 1/23/2024 |
S SentinelOne | $23.03
-0.3% | 1/22/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $30.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 1/22/2024 |
MTTR Matterport | $4.56
+0.9% | 1/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of Matterport (NASDAQ:MTTR) on 1/19/2024 |
SMRT SmartRent | $2.48
+2.1% | 1/19/2024 | Initiated by | BTIG Research | - | Buy | $4.50 | Low | View details for BTIG Research rating of SmartRent (NYSE:SMRT) on 1/19/2024 |
CSGP CoStar Group | $78.51
+0.9% | 1/19/2024 | Initiated by | BTIG Research | - | Neutral | | Low | View details for BTIG Research rating of CoStar Group (NASDAQ:CSGP) on 1/19/2024 |
APPF AppFolio | $230.95
-10.9% | 1/19/2024 | Initiated by | BTIG Research | - | Buy | $215.00 | Low | View details for BTIG Research rating of AppFolio (NASDAQ:APPF) on 1/19/2024 |
PSFE Paysafe | $21.67
+3.2% | 1/17/2024 | Initiated by | BTIG Research | - | Buy | $19.00 | Low | View details for BTIG Research rating of Paysafe (NYSE:PSFE) on 1/17/2024 |
MARA Marathon Digital | $21.57
+6.4% | 1/17/2024 | Upgraded by | BTIG Research | - | Neutral -> Buy | $27.00 | Low | View details for BTIG Research rating of Marathon Digital (NASDAQ:MARA) on 1/17/2024 |
ACRS Aclaris Therapeutics | $1.39
+3.0% | 1/11/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Aclaris Therapeutics (NASDAQ:ACRS) on 1/11/2024 |
BIIB Biogen | $211.17
-7.2% | 1/7/2024 | Reiterated by | BTIG Research | Analyst T. Shrader | Neutral | | Low | View details for BTIG Research rating of Biogen (NASDAQ:BIIB) on 1/7/2024 |
PYPL PayPal | $58.29
+1.9% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of PayPal (NASDAQ:PYPL) on 1/5/2024 |
GOGL Golden Ocean Group | $12.48
-0.5% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Golden Ocean Group (NASDAQ:GOGL) on 1/5/2024 |
GNK Genco Shipping & Trading | $19.56
-0.6% | 1/5/2024 | Reiterated by | BTIG Research | - | Buy -> Neutral | | Low | View details for BTIG Research rating of Genco Shipping & Trading (NYSE:GNK) on 1/5/2024 |
CMG Chipotle Mexican Grill | $49.81
-2.0% | 1/4/2024 | Target Raised by | BTIG Research | - | Buy | $43.50 -> $53.00 | Low | View details for BTIG Research rating of Chipotle Mexican Grill (NYSE:CMG) on 1/4/2024 |
NTRA Natera | $102.67
+0.5% | 12/29/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $85.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 12/29/2023 |
NEO NeoGenomics | $14.88
-1.3% | 12/29/2023 | Target Lowered by | BTIG Research | - | Buy -> Buy | $25.00 -> $21.00 | Low | View details for BTIG Research rating of NeoGenomics (NASDAQ:NEO) on 12/29/2023 |
HPP Hudson Pacific Properties | $5.74
+7.9% | 12/29/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $11.00 -> $13.00 | Low | View details for BTIG Research rating of Hudson Pacific Properties (NYSE:HPP) on 12/29/2023 |
BSX Boston Scientific | $74.95
+0.9% | 12/29/2023 | Reiterated by | BTIG Research | - | Buy -> Buy | $64.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 12/29/2023 |
LSPD Lightspeed Commerce | $13.32
+2.1% | 12/28/2023 | Target Raised by | BTIG Research | - | Buy | $20.00 -> $24.00 | Low | View details for BTIG Research rating of Lightspeed Commerce (NYSE:LSPD) on 12/28/2023 |
ORGO Organogenesis | $3.24
+0.6% | 12/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $4.00 -> $6.00 | Low | View details for BTIG Research rating of Organogenesis (NASDAQ:ORGO) on 12/27/2023 |
EXPE Expedia Group | $125.87
+0.8% | 12/27/2023 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $175.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 12/27/2023 |
